>>> LATEST NEWS...Delegate Update: Big Pharma chooses Oncology Summit Europe, including: Roche, Sanofi-Aventis, GSK, Johnson & Johnson, AstraZeneca, Merck Serono, Bristol-Myers Squibb, Schering-Plough, Wyeth, Bayer Healthcare... >>> LATEST NEWS...Delegate Update: Big Pharma chooses Oncology Summit Europe, including: Roche, Sanofi-Aventis, GSK, Johnson & Johnson, AstraZeneca, Merck Serono, Bristol-Myers Squibb, Schering-Plough, Wyeth, Bayer Healthcare... >>> LATEST NEWS...Delegate Update: Big Pharma chooses Oncology Summit Europe, including: Roche, Sanofi-Aventis, GSK, Johnson & Johnson, AstraZeneca, Merck Serono, Bristol-Myers Squibb, Schering-Plough, Wyeth, Bayer Healthcare...

Oncology Summit Europe

 

30th January - DAY ONE

8.20 AM

Pre-conference registration and light breakfast

9.20 AM

Chairman's opening remarks

Sean McGrath, Managing Director, Succinct Healthcare Communications and Consultancy

 

Address The Patient Challenges

9.30 AM

Cancer Care in Europe – a Patchwork of Provision Across a Continent

Prof Karol Sikora, Medical Director, Cancer Patients UK

10.10 AM

Collaborate Effectively with Patient Groups

Jola Gore-Booth, Chief Executive, europacolon

10.50 AM

Networking Break & Exhibition (40 minutes)

 

Pricing, Access and Reimbursement

11.30 AM

Budget Impact Models or Cost-Effective Analysis?

Eddie Gibson, Business Unit Director, Oncology , BMS

12.10 PM

Market Access and Managed Entry with Oncology Drugs in Europe

Chris Teale, Director, Global Pricing and Market Access Strategy , AstraZeneca

12.50 PM

Networking Lunch & Exhibition (1 hour 10 minutes)

2.00 PM

Key Success Factors for Launching Oncology Products in Europe

Nader Naeymi-Rad, Senior Vice President, Brand Management Practice, Campbell Alliance

2.40PM

Pricing for Outcome and Risk Sharing: How Should Pharma React Next?

Uday Bose, European Marketing Director, GSK

3.20 PM

Break & Exhibition (30 minutes)

3.50 PM

New Targeted Drugs or Newer Niche Indications – Who Benefits, Who Pays?

John De Wit, Business Unit Director, Oncology, Amgen

 

Marketing Best Practice in Oncology

4.30 PM

Is Oncology Marketing a Special Case? How can we Adopt a Leadership Position?

Gary Hendler , Associate VP, Oncology Marketing , sanofi-aventis

5:10 PM

End of Day One Questions and Chairman's Closing Remarks

 

 

 

31st January- DAY TWO

9.00 AM

Introduction to Day Two

Sean McGrath, Managing Director, Succinct Healthcare Communications and Consultancy

 

Working with Healthcare and Service Providers

9.10 AM

Work in Partnership with Government and Healthcare Providers to Improve Patient Access to Cancer Medicines

Jackie Holding , Consultant, Holding Associates

9.50 AM

Discover the Most Innovative Emerging Local and Regional Cancer Therapy Devices

Crispin Simon, CEO, Biocompatibles

10.30 AM

Networking Break & Exhibition (40 minutes)

11.10 AM

Oncology Trends and Future Challenges and Opportunities

Graham Lewis, VP Europe, Global Pharma Strategy, IMS

11.50 AM

The Patient of 2020: A Look At Cancer Care In The Near Future

Prof Gordon McVie, Senior Consultant , European Institute of Oncology

12.30 AM

Special Question Time Session

Hosted by: Prof Gordon McVie , Senior Consultant, European Institute of Oncology

1.15 PM

Lunch & Exhibition (1 hour)

2:15 PM

CLOSE OF CONFERENCE

 

 

Event Overview
Who Will I Meet?
Programme
Attendee Benefits
Register Now
Testimonials
Sponsorship&Expo
Free White Papers
Media Partners
Venue
About the Sponsors
Global Sponsor:
Gold Sponsor:
Gold Exhibitor:
Silver Exhibitor:
Media Partners: